BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34705516)

  • 1. Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer.
    Ro V; McGuinness JE; Guo B; Trivedi MS; Jones T; Chung WK; Rao R; Levinson E; Koval C; Russo D; Chilton I; Kukafka R; Crew KD
    JCO Oncol Pract; 2022 Apr; 18(4):e472-e483. PubMed ID: 34705516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Management of Patients at Risk for Hereditary Breast Cancer with Variants of Uncertain Significance in the Era of Multigene Panel Testing.
    Chang J; Seng S; Yoo J; Equivel P; Lum SS
    Ann Surg Oncol; 2019 Oct; 26(10):3389-3396. PubMed ID: 31342386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
    Elsayegh N; Webster RD; Gutierrez Barrera AM; Lin H; Kuerer HM; Litton JK; Bedrosian I; Arun BK
    Cancer Med; 2018 Jun; 7(6):2718-2726. PubMed ID: 29733510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.
    Pederson HJ; Gopalakrishnan D; Noss R; Yanda C; Eng C; Grobmyer SR
    J Am Coll Surg; 2018 Apr; 226(4):560-565. PubMed ID: 29360614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
    Zhang JQ; Dos Anjos CH; Sevilimedu V; Crown A; Amoroso KA; Pilewskie ML; Robson ME; Gemignani ML
    Ann Surg Oncol; 2023 Nov; 30(12):6990-6999. PubMed ID: 37661222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta-analysis.
    Makhnoon S; Bednar EM; Krause KJ; Peterson SK; Lopez-Olivo MA
    Clin Genet; 2021 Aug; 100(2):119-131. PubMed ID: 33843052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of germline test results on surgical decision making in women with invasive breast cancer.
    Vargason AB; Turner CE; Shriver CD; Ellsworth RE
    Cancer Genet; 2022 Aug; 266-267():81-85. PubMed ID: 35868102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in
    Makhnoon S; Gutierrez Barrera AM; Bassett R; Afrough A; Bedrosian I; Arun BK
    Breast J; 2022; 2022():1447545. PubMed ID: 36685664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes.
    Makhnoon S; Chen M; Levin B; Ensinger M; Mattie KD; Grana G; Shete S; Arun BK; Peterson SK
    Cancer; 2022 Oct; 128(20):3709-3717. PubMed ID: 35996941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
    Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
    Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
    Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD
    Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients.
    Jones T; Trivedi MS; Jiang X; Silverman T; Underhill M; Chung WK; Kukafka R; Crew KD
    J Cancer Educ; 2021 Jun; 36(3):463-469. PubMed ID: 31802423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
    Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
    Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
    Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
    Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
    Murphy BL; Yi M; Arun BK; Gutierrez Barrera AM; Bedrosian I
    Ann Surg Oncol; 2020 Nov; 27(12):4613-4621. PubMed ID: 32720048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
    Terkelsen T; Rønning H; Skytte AB
    Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic testing and surgical treatment after breast cancer diagnosis: Results from a national online cohort.
    Verdial FC; Bartek MA; Anderson BO; Javid SH
    J Surg Oncol; 2021 Jun; 123(7):1504-1512. PubMed ID: 33735483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.